Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by 4real4everon Dec 05, 2021 1:58pm
100 Views
Post# 34200122

RE:RE:RE:My 2 cents

RE:RE:RE:My 2 cents

SZLS was Genenews before and created in 1997

25 years ago

Share price was 10x higher in 2004-08
 

 

MarketMoney wrote: SZLS started small and getting bigger and bigger.  The science used in SZLS is so ingenious that they can replicate for many form of detection of other diseases. The sky is the limit and their getting better at what they are doing!

What I see COVID brought to SZLS is really interesting. They are able to keep their technician busy and employ more employee so they can be ready to receive Aristotle testing from futur client.  In other words they don't need to fire lab technician and keep their full force for new testing so growth is not restrained.

What's really awesome is the word is getting out to the world! Either by having high volume transaction, high volativity of stock and many news and marketting showing on tv, web etc.

SZLS is now a nice piece of bussiness to own for a bigger pharma that are willing to add this technology which is ready to use and much potential to built from. Either SZLS grows by itself or gets bought by another big player, either way the futur is very nice for this company.

Have a great day

 

<< Previous
Bullboard Posts
Next >>